These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 2642985)

  • 21. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.
    Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST
    Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
    Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
    Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An Alzheimer's disease case showing recurrent subcortical hemorrhage: an autopsy findings with immunohistochemical studies of cerebral amyloid deposits].
    Maruyama K; Ikeda S; Odajima N; Yanagisawa N
    Rinsho Shinkeigaku; 1989 Jul; 29(7):936-9. PubMed ID: 2805520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain.
    Thal DR; Ghebremedhin E; Haass C; Schultz C
    Clin Neuropathol; 2002; 21(1):35-40. PubMed ID: 11846043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
    Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
    Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
    Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
    Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exclusive association and simultaneous appearance of congophilic plaques and AT8-positive dystrophic neurites in Tg2576 mice suggest a mechanism of senile plaque formation and progression of neuritic dystrophy in Alzheimer's disease.
    Noda-Saita K; Terai K; Iwai A; Tsukamoto M; Shitaka Y; Kawabata S; Okada M; Yamaguchi T
    Acta Neuropathol; 2004 Nov; 108(5):435-42. PubMed ID: 15372280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral extracellular preamyloid deposits in Alzheimer's disease, Down syndrome and nondemented elderly individuals.
    Tagliavini F; Giaccone G; Linoli G; Frangione B; Bugiani O
    Prog Clin Biol Res; 1989; 317():1001-5. PubMed ID: 2532368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
    van de Nes JA; Konermann S; Nafe R; Swaab DF
    Acta Neuropathol; 2006 Feb; 111(2):126-38. PubMed ID: 16456666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transgenic mouse brain histopathology resembles early Alzheimer's disease.
    Higgins LS; Holtzman DM; Rabin J; Mobley WC; Cordell B
    Ann Neurol; 1994 May; 35(5):598-607. PubMed ID: 7513982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PDAPP; YFP double transgenic mice: a tool to study amyloid-beta associated changes in axonal, dendritic, and synaptic structures.
    Brendza RP; O'Brien C; Simmons K; McKeel DW; Bales KR; Paul SM; Olney JW; Sanes JR; Holtzman DM
    J Comp Neurol; 2003 Feb; 456(4):375-83. PubMed ID: 12532409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.
    Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P
    Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain.
    Higgins LS; Murphy GM; Forno LS; Catalano R; Cordell B
    Am J Pathol; 1996 Aug; 149(2):585-96. PubMed ID: 8701997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The presence of isoaspartic acid in beta-amyloid plaques indicates plaque age.
    Fonseca MI; Head E; Velazquez P; Cotman CW; Tenner AJ
    Exp Neurol; 1999 Jun; 157(2):277-88. PubMed ID: 10364440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease.
    Dickson TC; King CE; McCormack GH; Vickers JC
    Exp Neurol; 1999 Mar; 156(1):100-10. PubMed ID: 10192781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The pathogenesis of Alzheimer's disease demonstrated by immunocytochemistry with anti-beta-protein antibody].
    Ikeda S
    Yakubutsu Seishin Kodo; 1992 Jun; 12(3):141-9. PubMed ID: 1414034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The presence of a novel protein in calf serum that recognizes beta amyloid in the formalin-fixed section.
    Kanemaru K; Hasegawa M; Shimada H; Ihara Y
    Am J Pathol; 1990 Sep; 137(3):677-87. PubMed ID: 1698030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-protein amyloid is widely distributed in the central nervous system of patients with Alzheimer's disease.
    Ogomori K; Kitamoto T; Tateishi J; Sato Y; Suetsugu M; Abe M
    Am J Pathol; 1989 Feb; 134(2):243-51. PubMed ID: 2464938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The copper-peroxide-silver method: a highly sensitive procedure for the demonstration of Alzheimer's disease lesions and for signal intensification in immunocytochemistry.
    Velasco ME
    Mod Pathol; 1992 Jul; 5(4):455-63. PubMed ID: 1495951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.